Key genetic variants may affect how cancer patients respond to radiation treatments, according to a clinical study published this week in Nature Genetics.
If you enjoy this content, please share it with a colleague
July 31, 2014 — Varian Medical Systems announced its Aria oncology information system (OIS) has been certified to demonstrate stage 1 and 2 meaningful use (MU) of an electronic health record (EHR).
July 31, 2014 — A radiation expert from the University of Texas MD Anderson Cancer Center can now add innovator and entrepreneur to his list of accomplishments following the conception and development of a new device approved by the U.S. Food and Drug Administration (FDA) for prostate cancer.
July 31, 2014 — VuCOMP announced it has amended its Health Canada medical device license to include M-Vu Breast Density. The amendment provides clearance for VuCOMP to sell and market its M-Vu Breast Density product throughout Canada.
An innovative new data collection system could revolutionize the way doctors provide treatment, helping them improve outcomes and decrease side effects for cancer patients, according to research presented at the 56th Annual Meeting of the American Association of Physicists in Medicine (AAPM).
July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual meeting of the American Association of Physicists in Medicine (AAPM) in Austin, Texas.
If you enjoy this content, please share it with a colleague
Study data presented at the Alzheimer’s Association International Conference in Copenhagen further demonstrates the diagnostic value of GE Healthcare’s investigational radiopharmaceutical product [18F]flutemetamol in confirming the presence of neuritic amyloid in those patients with early onset dementia.
